<html>
<head>PUBMED IDs for TRIP2</head>
<body bgcolor='#C5F0F2'><h1>TRIP2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9989412/'>The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1.</a> February 16  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/9989397/'>Risks inherent in fetal gene therapy.</a> February 16  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/15485806/'>Recruitment of thyroid hormone receptor/retinoblastoma-interacting protein 230 by the aryl hydrocarbon receptor nuclear translocator is required for the transcriptional response to both dioxin and hypoxia.</a> October 16  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/18782753/'>A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein.</a> September 11  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/24919196/'>A TRIP230-retinoblastoma protein complex regulates hypoxia-inducible factor-1Î±-mediated transcription and cancer cell invasion.</a> February 3  2014<br></body></html>
